Mirion Technologies Inc. Class A Common Stock (MIR)

FairStock Score: 30/100 — RISKY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I am always wary of paying a high price for a turnaround, even one with a useful niche. Mirion sells radiation detection, measurement, analysis, and monitoring products and services for medical and nuclear safety customers. Revenue has grown: in fiscal 2025, the year ended 2025-12-31, revenue was $925.4 million, up from $860.8 million in fiscal 2024, the year ended 2024-12-31, and $800.9 million in fiscal 2023, the year ended 2023-12-31. It also returned to profit: fiscal 2025 net income was $28.8 million, versus losses of $36.1 million in fiscal 2024 and $96.9 million in fiscal 2023. In fiscal Q2 2026, the quarter ended 2026-06-30, revenue was $266.8 million and net income was $7.7 million, a 2.89% margin.

In plain English: Mirion makes radiation detection and monitoring equipment used in medical care and nuclear safety. The company is selling more each year and has returned to profit, but profit margins are very thin and returns on money invested are low. At the 2026-10-13 close of $16.42, the shares look expensive compared with those profits and the company's accounting value.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer